Linezolid is Oxazolidinone class of antibiotic which inhibits the initial phase of bacterial protein synthesis. It is bacteriostatic in nature. It has 100% bioavailability with oral form, hence ensures rapid switch over from IV to oral.
Linezolid achieves excellent penetration into infected soft tissue and bone. It achieves 100% concentration in Epithelial Lining Fluid (ELF).